NCT00599950

Brief Summary

To evaluate the confocal microscopy changes in keratocyte density at the anterior stromal after Photorefractive keratectomy (PRK) surgery, using intraoperative mitomycin C(Mitolem, LEMERY, S.A. de C.V. Mexico D.F. Reg. 136M92 SSA).

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
10

participants targeted

Target at below P25 for phase_4

Timeline
Completed

Started Jan 2007

Shorter than P25 for phase_4

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2007

Completed
Same day until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2007

Completed
10 months until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2007

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

January 8, 2008

Completed
16 days until next milestone

First Posted

Study publicly available on registry

January 24, 2008

Completed
Last Updated

May 30, 2024

Status Verified

May 1, 2024

Enrollment Period

Same day

First QC Date

January 8, 2008

Last Update Submit

May 29, 2024

Conditions

Keywords

Mitomycin CCorneal epitheliumPhotorefractive keratectomy (PRK)Confocal microscope

Outcome Measures

Primary Outcomes (1)

  • A central scan of the anterior stroma was taken with the confocal microscope (Confoscan 4, Fortune Technologies, Italy)

    Before surgery and 1 week, 1 month, 3 months, 6 months after surgery

Study Arms (2)

1

EXPERIMENTAL

Topical mitomycin C on the corneal epithelium of patients undergoing photorefractive keratectomy (PRK)

Drug: Mitomycin C and Photorefractive keratectomy (PRK)

2

PLACEBO COMPARATOR

Photorefractive keratectomy (PRK)without mitomycin C.

Drug: Mitomycin C and Photorefractive keratectomy (PRK)

Interventions

Topical mitomycin C on the corneal epithelium of patients undergoing photorefractive keratectomy (PRK)

12

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients ask for PRK surgery
  • Patients with stable refraction in the last year
  • Patients without systemic and ocular disease
  • Patients with 500 microns in pachymetry normal topography

You may not qualify if:

  • Patients cannot attend their appointments
  • Residual, recurrent or active ocular disease
  • Previous ocular surgery except PRK
  • Autoimmune or connective tissue disease
  • Pregnancy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Asociación Para Evitar la Ceguera en Mëxico, Hospital "Luis Sánchez Bulnes".

Mexico City, Mexico City, 04030, Mexico

Location

Related Publications (3)

  • Midena E, Gambato C, Miotto S, Cortese M, Salvi R, Ghirlando A. Long-term effects on corneal keratocytes of mitomycin C during photorefractive keratectomy: a randomized contralateral eye confocal microscopy study. J Refract Surg. 2007 Nov;23(9 Suppl):S1011-4. doi: 10.3928/1081-597X-20071102-06.

    PMID: 18046999BACKGROUND
  • Ghirlando A, Gambato C, Midena E. LASEK and photorefractive keratectomy for myopia: clinical and confocal microscopy comparison. J Refract Surg. 2007 Sep;23(7):694-702. doi: 10.3928/1081-597X-20070901-08.

    PMID: 17912939BACKGROUND
  • Ying L, Xiao Z, Liuxueying Z, Yumei J. Clinical use of in vivo confocal microscopy through focusing in corneal refractive surgery. J Refract Surg. 2006 Nov;22(9 Suppl):S1041-6. doi: 10.3928/1081-597X-20061102-07.

    PMID: 17444091BACKGROUND

MeSH Terms

Conditions

Refractive Errors

Interventions

MitomycinPhotorefractive Keratectomy

Condition Hierarchy (Ancestors)

Eye Diseases

Intervention Hierarchy (Ancestors)

MitomycinsIndolequinonesQuinonesOrganic ChemicalsAzirinesHeterocyclic Compounds, 1-RingHeterocyclic CompoundsIndolesHeterocyclic Compounds, 2-RingHeterocyclic Compounds, Fused-RingCorneal Surgery, LaserLaser TherapyTherapeuticsAblation TechniquesSurgical Procedures, OperativeKeratectomyRefractive Surgical ProceduresOphthalmologic Surgical Procedures

Study Officials

  • Ramirez F Manuel, MD

    Asociación para Evitar la Ceguera en México

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
phase 4
Allocation
NON RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER

Study Record Dates

First Submitted

January 8, 2008

First Posted

January 24, 2008

Study Start

January 1, 2007

Primary Completion

January 1, 2007

Study Completion

November 1, 2007

Last Updated

May 30, 2024

Record last verified: 2024-05

Locations